Revenue (Quarterly) Chart

View Revenue (Quarterly) for UBEOF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (Quarterly) Chart
Start Trial

Historical Revenue (Quarterly) Data

View and export this data back to 2003. Start Trial.
Date Value
March 31, 2026 829.80M
December 31, 2025 775.27M
September 30, 2025 761.36M
June 30, 2025 694.89M
March 31, 2025 834.49M
December 31, 2024 765.07M
September 30, 2024 855.39M
June 30, 2024 740.46M
March 31, 2024 911.18M
December 31, 2023 776.66M
September 30, 2023 753.04M
June 30, 2023 794.13M
March 31, 2023 954.28M
December 31, 2022 873.79M
September 30, 2022 929.92M
June 30, 2022 896.51M
March 31, 2022 1.536B
December 31, 2021 1.494B
September 30, 2021 1.457B
June 30, 2021 1.337B
March 31, 2021 1.649B
December 31, 2020 1.521B
September 30, 2020 1.356B
June 30, 2020 1.266B
March 31, 2020 1.560B
Date Value
December 31, 2019 1.498B
September 30, 2019 1.584B
June 30, 2019 1.502B
March 31, 2019 1.722B
December 31, 2018 1.704B
September 30, 2018 1.607B
June 30, 2018 1.549B
March 31, 2018 1.741B
December 31, 2017 1.594B
September 30, 2017 1.510B
June 30, 2017 1.436B
March 31, 2017 1.556B
December 31, 2016 1.450B
September 30, 2016 1.397B
June 30, 2016 1.280B
March 31, 2016 1.384B
December 31, 2015 1.310B
September 30, 2015 1.325B
June 30, 2015 1.329B
March 31, 2015 1.410B
December 31, 2014 1.451B
September 30, 2014 1.531B
June 30, 2014 1.455B
March 31, 2014 1.691B
December 31, 2013 1.653B

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Quarterly) Range, Past 5 Years

View Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (Quarterly) Benchmarks

View Revenue (Quarterly) Benchmarks
Start Trial
Shin-Etsu Chemical Co., Ltd. 4.079B
Kuraray Co., Ltd. 1.281B
Kaneka Corp. 1.360B
Daicel Corp. 986.66M
Asahi Kasei Corp. 5.183B